Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 18:23:02 - browse：84

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： STAT Readout: Friday, Oct. 20 biotech updates

entertainment

WSS

Is there really a nursing shortage in the U.S.?

UnitedHealth, Optum discontinue NaviHealth name

Health tech investors get more selective as pandemic boom fades

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Altering the blood type of lungs raises potential for universal organs for transplants

leisure time

Wikipedia

focus

In age of alternative facts, a scholarly course on calling out crap

Inside the rise of 'mukbang' eating videos

Jerome Adams on the need for new antivirals for Covid

STAT Summit: The economic case for universal basic health care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Is there really a nursing shortage in the U.S.?

Activists slam private health insurers over coverage restrictions

J&J lung cancer data amount to new salvo against AstraZeneca

United colonoscopy coverage change 'may cost lives,' doctors say

Smaller biotechs seek to piggyback on weight loss drug boom

entertainment

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Health tech investors get more selective as pandemic boom fades

Roche drug slashes death risk in early

Eli Lilly’s Mounjaro succeeds in second weight

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

focus

entertainment

leisure time

hotspot